Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net (loss) income	$ (12.3)	$ 11.6
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	45.2	37.9
Non-cash interest expense (income), net	2.2	0.1
Equity-based compensation expense	6.9	4.9
Loss (gain) on disposals and deconsolidations, net	6.4	(7.6)
Loss on debt extinguishment	0.0	11.7
Deferred income taxes	(16.4)	2.0
(Loss) income from equity investments, net of distributions received	(0.2)	0.1
Non-cash lease expense	20.1	19.6
Changes in operating assets and liabilities, net of acquisitions and divestitures:
Accounts receivable	16.3	6.9
Medicare accelerated payments and deferred governmental grants	124.7	0.0
Other operating assets and liabilities	18.2	(40.0)
Net cash provided by operating activities	211.1	47.2
Cash flows from investing activities:
Purchases of property and equipment	(19.9)	(31.8)
Payments for acquisitions, net of cash acquired	(12.4)	(13.2)
Proceeds from disposals of facilities and other assets	9.4	17.6
Purchases of equity investments	0.0	(15.2)
Other investing activities	0.4	(0.3)
Net cash used in investing activities	(22.5)	(42.9)
Cash flows from financing activities:
Principal payments on long-term debt	(182.8)	(422.8)
Borrowings of long-term debt	288.2	438.9
Payments of debt issuance costs	(6.5)	(8.8)
Payment of premium on debt extinguishment	0.0	(17.8)
Distributions to non-controlling interest holders	(51.7)	(60.9)
(Payments) receipts related to ownership transactions with non-controlling interest holders	(1.9)	1.2
Other financing activities	(0.3)	(1.0)
Net cash provided by (used in) financing activities	45.0	(71.2)
Net increase (decrease) in cash, cash equivalents and restricted cash	233.6	(66.9)
Cash, cash equivalents and restricted cash at beginning of period	93.0	184.6
Cash, cash equivalents and restricted cash at end of period	$ 326.6	$ 117.7